Meta-analysis of the association between RASSF1A gene promoter methylation and non-small cell lung cancer

Chinese Journal of Lung Cancer

Volumn 18, Issue 7, 2015, Pages 443-450

  Wei, Huijun ^a   Fang, Nianzhen ^a   Guo, Lili ^a   Wu, Zhihao ^a   Zhou, Qinghua ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Lung neoplasms; Meta analysis; Methylation; RASSF1A gene

Indexed keywords

RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; RASSF1 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; DNA METHYLATION; GENETIC ASSOCIATION; HUMAN; META ANALYSIS; NON SMALL CELL LUNG CANCER; PROMOTER REGION; DISEASE COURSE; GENETICS; LUNG TUMOR; METABOLISM; PATHOLOGY;

CARCINOMA, NON-SMALL-CELL LUNG; DISEASE PROGRESSION; DNA METHYLATION; HUMANS; LUNG NEOPLASMS; PROMOTER REGIONS, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 84937579722     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2015.07.09     Document Type: Article

References (30)

1. Siegel R, Miller KD, Jemal A, et al. Cancer statistics, 2014. CA Cancer J Clin, 2014, 64(1): 9-29.
2. Risch A, Plass C. Lung cancer epigenetics and genetics. Int J Cancer, 2008, 123(1): 1-7.
3. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 1959, 22(4): 719-748.
4. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ, 1997, 315(7109): 629-634.
5. Hubers AJ, Heideman DA, Burgers SA, et al. DNA hypermethylation analysis in sputum for the diagnosis of lung cancer: training validation set approach. Br J Cancer, 2015, 112(6): 1105-1113.
6. Zhai X, Li SJ. Methylation of RASSF1A and CDH13 genes in individualized chemotherapy for patients with non-small cell lung cancer. Asian Pac J Cancer Prev, 2014, 15(12): 4925-4928.
7. Li W, Deng J, Tang JX. Combined effects methylation of FHIT, RASSF1A and RARbeta genes on non-small cell lung cancer in the Chinese population. Asian Pac J Cancer Prev, 2014, 15(13): 5233-5237.
8. Tan S, Sun C, Wei X, et al. Quantitative assessment of lung cancer associated with genes methylation in the peripheral blood. Exp Lung Res, 2013, 39(4-5): 182-190.
9. Li W, Deng J, Jiang P, et al. Methylation of the RASSF1A and RARbeta genes as a candidate biomarker for lung cancer. Exp Ther Med, 2012, 3(6): 1067-1071.
10. Lee SM, Lee WK, Kim DS, et al. Quantitative promoter hypermethylation analysis of RASSF1A in lung cancer: comparison with methylation-specific PCR technique and clinical significance. Mol Med Rep, 2012, 5(1): 239-244.
11. Song H, Yi J, Zhang Y, et al. DNA methylation of tumor suppressor genes located on chromosome 3p in non-small cell lung cancer. Zhongguo Fei Ai Za Zhi, 2011, 14(3): 233-238.
12. Zhang H, Zhang SC, Zhang ZD, et al. Prognostic value of methylation status of RASSF1A gene as an independent factor of non-small cell lung cancer. Zhongguo Fei Ai Za Zhi, 2010, 13(4): 311-316.
13. Helmbold P, Lahtz C, Herpel E, et al. Frequent hypermethylation of RASSF1A tumour suppressor gene promoter and presence of Merkel cell polyomavirus in small cell lung cancer. Eur J Cancer, 2009, 45(12): 2207-2211.
14. Lin Q, Geng J, Ma K, et al. RASSF1A, APC, ESR1, ABCB1 and HOXC9, but not p16INK4A, DAPK1, PTEN and MT1G genes were frequently methylated in the stage I non-small cell lung cancer in China. J Cancer Res Clin Oncol, 2009, 135(12): 1675-1684.
15. Liu Y, Lan Q, Shen M, et al. Aberrant gene promoter methylation in sputum from individuals exposed to smoky coal emissions. Anticancer Res, 2008, 28(4B): 2061-2066.
16. Brock MV, Hooker CM, Ota-Machida E, et al. DNA methylation markers and early recurrence in stage I lung cancer. N Engl J Med, 2008, 358(11): 1118-1128.
17. Yu ZH, Wang YC, Chen LB, et al. Analysis of RASSF1A promoter hypermethylation in serum DNA of non-small cell lung cancer. Zhonghua Zhong Liu Za Zhi, 2008, 30(4): 284-287.
18. Yanagawa N, Tamura G, Oizumi H, et al. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers. Lung Cancer, 2007, 58(1): 131-138.
19. Wang Y, Yu Z, Wang T, et al. Identification of epigenetic aberrant promoter methylation of RASSF1A in serum DNA and its clinicopathological significance in lung cancer. Lung Cancer, 2007, 56(2): 289-294.
20. Hsu HS, Chen TP, Hung CH, et al. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma. Cancer, 2007, 110(9): 2019-2026.
21. Chen H, Suzuki M, Nakamura Y, et al. Aberrant methylation of RASGRF2 and RASSF1A in human non-small cell lung cancer. Oncol Rep, 2006, 15(5): 1281-1285.
22. Ito M, Ito G, Kondo M, et al. Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in nonsmall cell lung cancer. Cancer Lett, 2005, 225(1): 131-139.
23. Fujiwara K, Fujimoto N, Tabata M, et al. Identification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancer. Clin Cancer Res, 2005, 11(3): 1219-1225.
24. Safar AM, Ito G, Kondo M, et al. Methylation profiling of archived non-small cell lung cancer: a promising prognostic system. Clin Cancer Res, 2005, 11(12): 4400-4405.
25. Choi N, Son DS, Song I, et al. RASSF1A is not appropriate as an early detection marker or a prognostic marker for non-small cell lung cancer. Int J Cancer, 2005, 115(4): 575-581.
26. Wang J, Lee JJ, Wang L, et al. Value of p16INK4a and RASSF1A promoter hypermethylation in prognosis of patients with resectable non-small cell lung cancer. Clin Cancer Res, 2004, 10(18 Pt 1): 6119-6125.
27. Burbee DG, Forgacs E, Zochbauer-Muller S, et al. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst, 2001, 93(9): 691-699.
28. Esteller M. Epigenetic changes in cancer. F1000 Biol Rep, 2011, 3: 9.
29. Dammann R, Li C, Yoon JH, et al. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet, 2000, 25(3): 315-319.
30. van der Weyden L, Adams DJ. The Ras-association domain family (RASSF) members and their role in human tumourigenesis. Biochim Biophys Acta, 2007, 1776(1): 58-85.